Assets
+ Zoll Medical
History
2021: Itamar Medical Sleep Breath Diagnosis Device Developer Purchase
On September 13, 2021, Zoll Medical announced the acquisition of Itamar Medical for $538 million. Under the terms of the agreement, Zoll will buy all outstanding shares of the developer of devices for diagnosing breathing disorders in sleep at a price of $31 per US deposited share (ADS). More details here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |